Related Experiment Video
Updated: May 12, 2026

Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation
Published on: January 16, 2019
Statistical challenges in the analysis of dynamic traits: implications for pharmacogenomic clinics
1Department of Statistics, Temple University, 1810N, 13th Street, Philadelphia, PA 19122, USA. kiranmoy.das@temple.edu
Abstract:
Analysis of dynamic traits is statistically challenging for several reasons. Since most of the dynamic traits result in irregular sparse longitudinal measurements, a unified approach for jointly modeling the mean trajectories and the underlying covariance structure is essential. When the traits are bivariate or multivariate in nature, modeling the covariance structure is really challenging. For the pharmacogenomic clinics, it is extremely important to have a comprehensive study of the whole biological system. In other words, if the traits under consideration result in some events (e.g., death, disease), then a joint analysis is required for the observed dynamic traits and the event-time. In statistics, there is a vast literature on such joint modeling using parametric, nonparametric and semiparametric approaches. In this article, we will discuss different aspects of modeling the longitudinal traits, their limitations and importance to pharmacogenomic clinics.
Related Concept Videos
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Pharmacogenetics and Pharmacogenomics: Overview
Principles of Pharmacogenetics: Types of Genetic Variants
Pharmacogenetics of Drug Metabolism: Overview
Pharmacogenomics: Identification of New Drug Targets
Analysis of Population Pharmacokinetic Data
